UiPath, Inc. (NYSE: PATH) saw its stock decline 1.7% to $11.45 during regular trading on the New York Stock Exchange Wednesday, underperforming the broader market. The S&P 500 ETF (SPY) slipped just 0.4%, while the tech-heavy Invesco QQQ Trust (QQQ) traded nearly flat. The move came without any fresh company-specific news, suggesting the drop was driven by sector-wide pressure on AI and automation names, as well as positioning tied to UiPath's recent buyback activity.
Q1 Earnings Beat, But ARR Growth Raises Questions
The company reported fiscal first-quarter revenue of $418 million, up 17% year-over-year, and annual recurring revenue (ARR) of $1.901 billion, up 12%. GAAP operating income came in at $28 million, marking a shift toward profitability. However, net new ARR of just $49 million signaled a slowdown in the pace of growth, with dollar-based net retention at 109% — solid but not accelerating.
Management guided for fiscal Q2 revenue of $395 million to $400 million, below the Q1 level, and full-year fiscal 2027 revenue of $1.776 billion to $1.781 billion, implying low double-digit growth from fiscal 2026. Founder and CEO Daniel Dines called Q1 a "strong start," while CFO Ashim Gupta highlighted "first quarter GAAP profitability."
Buyback Data Adds to Pressure
UiPath's own share repurchase activity may be adding to the stock's malaise. According to the company's 10-Q filing, it bought back 20.4 million Class A shares in Q1 at an average price of $11.47, and another 2.4 million shares at $9.63 between May 1 and May 15. With the stock now trading at $11.45, just below the Q1 buyback average, the market appears to be capping the stock near that level.
The company's balance sheet remains strong, with $1.42 billion in cash, equivalents, and marketable securities as of April 30, representing about 23% of its $6.05 billion market cap. That provides a floor, but investors are focused on the ARR trajectory and whether AI agents can reignite growth.
Wall Street Stays Cautious
Analyst sentiment remains mixed. According to MarketBeat, 14 analysts rate the stock as Hold, two as Buy, and one as Sell, with an average price target of $13.80. Recent target cuts include UBS's Radi Sultan lowering his to $12 from $13 on June 29, BMO's Keith Bachman to $13 from $14 on June 1, and DA Davidson's Lucky Schreiner to $12 from $13 on May 29.
Short interest is elevated at 126.25 million shares, or 32.28% of float, as of June 15. This creates a binary risk: if ARR disappoints, shorts could pile on; if the company beats its July ARR target of $1.929 billion to $1.934 billion, a short squeeze could follow.
Product Innovation and Sector Context
UiPath recently launched Maestro Case as part of its Maestro suite, aiming to handle complex enterprise workflows involving people, bots, and AI agents. Product chief Raghu Malpani noted that exceptions are "the norm" in such environments. The move is part of UiPath's strategy to move beyond basic robotic process automation into higher-value enterprise automation.
The broader AI automation sector also faced headwinds Wednesday, with ServiceNow (NOW) falling 3.4% and Microsoft (MSFT) dropping 1.4%, suggesting sector-wide rotation rather than company-specific issues.
